Concordia Healthcare Corp

63 articles about Concordia Healthcare Corp

• 

  AstraZeneca Unloads Three Asthma and Rhinitis Drugs to Covis Pharma for $350 ...

  11/6/2018

  AstraZeneca is unloading rights to Alvesco (ciclesonide) to treat persistent asthma, and Omnaris and Zetonna (ciclesonide) to treat nasal symptoms associated with rhinitis. The company indicates that the rights cover markets outside the United States and the U.S. royalties for the drugs.

• Concordia Announces Receipt of Nasdaq Initial Notice of Bid Price Requirement

  12/1/2017

  The Company's common shares traded below a bid price of US$1.00 for 30 consecutive business days from October 17, 2017, to November 28, 2017.

• Concordia Announces DELIVER Strategy

  9/6/2017

• Concordia Announces Release Date For DELIVER Strategy

  8/31/2017

• Concordia Announces Second Quarter 2017 Results

  8/11/2017

• Concordia Announces Release Date For Second Quarter 2017 Results

  7/28/2017

• Concordia Provides Update On Development Of Long-Term Growth Strategy

  6/21/2017

• Concordia Announces RedHill Biopharma Has Started Promoting Donnatal In The U.S.

  6/13/2017

• Concordia Announces Results Of Annual General And Special Meeting Of Shareholders

  6/12/2017

• Concordia Announces First Quarter 2017 Results

  5/10/2017

• Concordia Announces Two New Appointments To The Board Of Directors

  5/4/2017

• Concordia Announces Release Date For First Quarter 2017 Results

  5/3/2017

• Concordia Appoints David Price As Chief Financial Officer

  4/27/2017

• Concordia Announces Fourth Quarter and Fiscal 2016 Results

  3/15/2017

• Concordia Announces Release Date For Fourth Quarter And Year-End 2016 Results

  3/9/2017

• Concordia Grant Of Treble Damages Further Vindicates Marketing Rights Of Its Donnatal Brand

  3/6/2017

• Concordia Comments On CMA Statement Of Objections Related To Hydrocortisone 10mg

  3/3/2017

• Concordia Makes Final Earn Out Payment To Cinven

  2/1/2017

• RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement With Concordia For GI Drug Donnatal

  1/3/2017

• Concordia Announces Leadership Transition At International Segment

  12/28/2016